Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christina Dold

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
Frontiers in Immunology|September 15, 2023
Cellular immunity to SARS-CoV-2 following intrafamilial exposure in seronegative family membersCecilia Jay, Emily Adland, Anna Csala, et al.
Nature Medicine|September 30, 2021
Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infectionShuo Feng, Daniel J Phillips, Thomas White, et al.
NPJ Vaccines|May 5, 2026
Monovalent and multivalent OspA mRNA-LNP vaccines elicit functional antibodies and protect against Borrelia burgdorferi in miceMeredith B Finn, Graham Willsey, Carol Lyn Piazza, et al.
Science Translational Medicine|May 7, 2025
A phase 1/2a clinical trial to assess safety and immunogenicity of an adenoviral-vectored capsular group B meningococcal vaccineChristina Dold, Blanché Oguti, Laura Silva-Reyes, et al.
Ebiomedicine|July 2, 2022
An exploratory analysis of the response to ChAdOx1 nCoV-19 (AZD1222) vaccine in males and femalesNatalie Gabrielle Marchevsky, Grace Li, Parvinder Aley, et al.
Science (New York, N.Y.)|January 29, 2021
MAIT cell activation augments adenovirus vector vaccine immunogenicityNicholas M Provine, Ali Amini, Lucy C Garner, et al.
Journal of the American Society of Nephrology : JASN|April 1, 2022
SARS-CoV-2-Specific T Cell Responses Are Not Associated with Protection against Reinfection in Hemodialysis PatientsSushma Shankar, Joseph Beckett, Tom Tipton, et al.
Nature Medicine|July 5, 2019
Investigation of the role of typhoid toxin in acute typhoid fever in a human challenge modelMalick M Gibani, Elizabeth Jones, Amber Barton, et al.
Nature Communications|July 1, 2025
An mRNA vaccine encoding five conserved Group A Streptococcus antigensNichaela Harbison-Price, Ismail Sebina, Rhiannon A Bolton, et al.
Lancet (London, England)|July 24, 2020
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trialPedro M Folegatti, Katie J Ewer, Parvinder K Aley, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Frontiers in Immunology|September 15, 2023
Cellular immunity to SARS-CoV-2 following intrafamilial exposure in seronegative family membersCecilia Jay, Emily Adland, Anna Csala, et al.
Nature Medicine|September 30, 2021
Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infectionShuo Feng, Daniel J Phillips, Thomas White, et al.
NPJ Vaccines|May 5, 2026
Monovalent and multivalent OspA mRNA-LNP vaccines elicit functional antibodies and protect against Borrelia burgdorferi in miceMeredith B Finn, Graham Willsey, Carol Lyn Piazza, et al.
Science Translational Medicine|May 7, 2025
A phase 1/2a clinical trial to assess safety and immunogenicity of an adenoviral-vectored capsular group B meningococcal vaccineChristina Dold, Blanché Oguti, Laura Silva-Reyes, et al.
Ebiomedicine|July 2, 2022
An exploratory analysis of the response to ChAdOx1 nCoV-19 (AZD1222) vaccine in males and femalesNatalie Gabrielle Marchevsky, Grace Li, Parvinder Aley, et al.
Science (New York, N.Y.)|January 29, 2021
MAIT cell activation augments adenovirus vector vaccine immunogenicityNicholas M Provine, Ali Amini, Lucy C Garner, et al.
Journal of the American Society of Nephrology : JASN|April 1, 2022
SARS-CoV-2-Specific T Cell Responses Are Not Associated with Protection against Reinfection in Hemodialysis PatientsSushma Shankar, Joseph Beckett, Tom Tipton, et al.
Nature Medicine|July 5, 2019
Investigation of the role of typhoid toxin in acute typhoid fever in a human challenge modelMalick M Gibani, Elizabeth Jones, Amber Barton, et al.
Nature Communications|July 1, 2025
An mRNA vaccine encoding five conserved Group A Streptococcus antigensNichaela Harbison-Price, Ismail Sebina, Rhiannon A Bolton, et al.
Lancet (London, England)|July 24, 2020
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trialPedro M Folegatti, Katie J Ewer, Parvinder K Aley, et al.
Pageof 7